zibotentan

Also known as ZD 4054, ZD-4054, ZD4054

Zibotentan (INN; development code ZD4054) is an experimental anti-cancer drug candidate in development by AstraZeneca. It is an endothelin receptor antagonist.

Wikidata facts

Mass: 424.095374

Show 2 more facts

chemical formula: C₁₉H₁₆N₆O₄S
canonical SMILES: CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4

Sources (3)

via Wikidata · CC0

~1 min read

Article

2 sections

Contents

References
External links

Zibotentan (INN; development code ZD4054) is an experimental anti-cancer drug candidate in development by AstraZeneca. It is an endothelin receptor antagonist.

Zibotentan was granted fast track status for the treatment of prostate cancer by the FDA.